Cargando…
Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153199/ https://www.ncbi.nlm.nih.gov/pubmed/35637429 http://dx.doi.org/10.1186/s12885-022-09692-0 |
| _version_ | 1784717800789508096 |
|---|---|
| author | Ma, Heng Feng, Peng-Hui Yu, Shuang-ni Lu, Zhao-Hui Yu, Qi Chen, Jie |
| author_facet | Ma, Heng Feng, Peng-Hui Yu, Shuang-ni Lu, Zhao-Hui Yu, Qi Chen, Jie |
| author_sort | Ma, Heng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9153199 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91531992022-06-01 Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma Ma, Heng Feng, Peng-Hui Yu, Shuang-ni Lu, Zhao-Hui Yu, Qi Chen, Jie BMC Cancer Correction BioMed Central 2022-05-30 /pmc/articles/PMC9153199/ /pubmed/35637429 http://dx.doi.org/10.1186/s12885-022-09692-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Ma, Heng Feng, Peng-Hui Yu, Shuang-ni Lu, Zhao-Hui Yu, Qi Chen, Jie Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma |
| title | Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma |
| title_full | Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma |
| title_fullStr | Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma |
| title_full_unstemmed | Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma |
| title_short | Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma |
| title_sort | correction: identification and validation of tnfrsf4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153199/ https://www.ncbi.nlm.nih.gov/pubmed/35637429 http://dx.doi.org/10.1186/s12885-022-09692-0 |
| work_keys_str_mv | AT maheng correctionidentificationandvalidationoftnfrsf4asahighprofilebiomarkerforprognosisandimmunomodulationinendometrialcarcinoma AT fengpenghui correctionidentificationandvalidationoftnfrsf4asahighprofilebiomarkerforprognosisandimmunomodulationinendometrialcarcinoma AT yushuangni correctionidentificationandvalidationoftnfrsf4asahighprofilebiomarkerforprognosisandimmunomodulationinendometrialcarcinoma AT luzhaohui correctionidentificationandvalidationoftnfrsf4asahighprofilebiomarkerforprognosisandimmunomodulationinendometrialcarcinoma AT yuqi correctionidentificationandvalidationoftnfrsf4asahighprofilebiomarkerforprognosisandimmunomodulationinendometrialcarcinoma AT chenjie correctionidentificationandvalidationoftnfrsf4asahighprofilebiomarkerforprognosisandimmunomodulationinendometrialcarcinoma |